0,05. Доказательная медицина от магии до поисков бессмертия

White C. Research on smoking and lung cancer: A landmark in the history of chronic disease epidemiology // The Yale Journal of Biology and Medicine. 1990. Vol. 63. № 1. P. 29–46.

Mahmood S. S., Levy D., Vasan R. S., Wang T. J. The framingham heart study and the epidemiology of cardiovascular diseases: A historical perspective // Lancet. 2014. March 15. Vol. 383. № 9921. P. 999–1008.

Song J. W., Chung K. C. Observational studies: Cohort and case-control studies // Plastic and reconstructive surgery. 2010. December. Vol. 126. № 6. P. 2234–2242.

Ending the tobacco problem: A blueprint for the nation. Washington, DC: Institute of Medicine, 2007.

Ridge C. A., McErlean A. M., Ginsberg M. S. Epidemiology of Lung Cancer // Seminars in interventional radiology. 2013. June. Vol. 30. № 2. P. 93–98.

Talhout R., Schulz T., Florek E., Van Benthem J., Wester P., Opperhuizen A. Hazardous compounds in tobacco smoke // International journal of environmental research and public health. 2011. February. Vol. 8. № 2. P. 613–628.

Pfeifer G. P, Denissenko M. F., Olivier M., Tretyakova N., Hecht S. S., Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers // Oncogene. 2002. October. Vol. 21. P. 7435–7451.

Hecht S. S. Tobacco smoke carcinogens and lung cancer // Journal of the National Cancer Institute. 1999. July 21. Vol. 91. № 14. P. 1194–1210.

Hecht S. S. Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: old and new // Carcinogenesis. 2005. Vol. 26. № 9. P. 1488–1492.

Tobacco smoke and involuntary smoking / IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 83. International Agency for Research on Cancer, Lyon, 2004.

Glantz S. A., Bero L. A., Slade J., Barnes D. E., Hanauer P. (eds.). The Cigarette Papers. University of California Press, 1998.

Fisher R. Cigarettes, cancer, and statistics // The Centennial Review of Arts & Science. 1958. Vol. 2. P. 151–166.

Heath C. W. Differences between smokers and nonsmokers // Archives of Internal Medicine. 1958. February. Vol. 101. № 2. P. 377–388.

Morris J. N., Crawford M. D. Coronary heart disease and physical activity of work: Evidence of a national necropsy survey // British Medical Journal. 1958. December 20. Vol. 2. № 5111. P. 1485–1496.

Morris J. N., Clayton D. G., Everitt M. G., Semmence A. M., Burgess E. H. Exercise in leisure time: coronary attack and death rates // British heart journal. 1990. Vol. 63. № 3. P. 325–334.

Fedak K. M., Bernal,A., Capshaw Z. A., Gross S. Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology // Emerging themes in epidemiology. 2015. Vol. 12. № 1. P. 14.

Howick J., Glasziou P., Aronson J. K. The evolution of evidence hierarchies: what can Bradford Hill’s ‘guidelines for causation’ contribute? // Journal of the Royal Society of Medicine. 2009. Vol. 102. № 5. P. 186–194.

Di Cicco M. E., Ragazzo V., Jacinto T. Mortality in relation to smoking: the British Doctors Study // Breathe (Sheffield, England). 2016. September. Vol. 12. № 3. P. 275–276.

Dearlove J. V., Bialous S. A., Glantz S. A. Tobacco industry manipulation of the hospitality industry to maintain smoking in public places // Tobacco Control. 2002. Vol. 11. № 2. P. 94–104.

Smith C. N., Kraemer J. D., Johnson A. C., Mays D. Plain packaging of cigarettes: do we have sufficient evidence? // Risk management and healthcare policy. 2015. Vol. 8. P. 21–30.